CVS's own survey found 77% of employers worry about GLP-1 costs and 80% have limited or are weighing limits on weight loss coverage.
Recap by typeshit. Full story at CVS Health.
Korea's first homegrown GLP-1 obesity drug, efpeglenatide, comes in about 25% below Wegovy and 40% below Mounjaro for its first four weeks.
MedPage Today
She's screened for diabetes at a BMI of 23 but denied a GLP-1 until 30. She argues insurers should use ethnicity-adjusted thresholds that guidelines already publish.
Pharmacist Paige notes the second round of Medicare drug price negotiation starts January 1, 2027, with the semaglutide family on the list.
New generics and steady prices drove the jump in sales value, with Eli Lilly's tirzepatide leading the market.
Jenner says nausea kept her from working, so her doctor moved her to a peptide shot. The catch: semaglutide and tirzepatide are peptides too.
An explainer on which weight loss medicines Novo Nordisk makes and its main product lineup, from the outlet's ongoing GLP-1 series.
Loading…